Taylor Wessing focuses on the mid-cap segment and offers support in traditional PE transactions as well as acquisitions, restructurings, exits, buy-and-build strategies and management participations. The team is experienced in advising portfolio shareholders and investors; the latter was among the recent growth areas. Maria Weiers (buy-outs and exits) and Michael Stein (buy-and-build strategies for financial investors) jointly lead the practice, which regularly advises across the life sciences, healthcare and technology sectors. The team was recently strengthened with the addition of Sven Schweneke (carve-out transactions and group restructurings) from Norton Rose Fulbright in June 2024 and the appointment of Marcel Leines (buy-outs and exits) to partner in January 2024.
Testimonials
Collated independently by Legal 500 research team.
- 'Very committed team, good expertise, very structured.'
- 'Christopher Peine – very good!'
Key clients
- AFINUM
- Alpina Partners
- Apheon Capital / Ortivity
- Borromin Capital Fund IV
- Cordet Capital Partners
- Digital Solution Group GmbH
- EQT Infrastructure
- Equistone
- GREYHOUND Software
- Inflexion
- International Chemical Investors Group (ICIG)
- Kiteworks
- Mercurius Health
- Mimo Capital AG
- NordHolding / Zentrum Gesundheit Gruppe
- Oakley Capital und IU Group
- Oberberg Gruppe (Trilantic)
- Pinova
- Protect Medical Holding GmbH (Borromin Capital)
- Sanecum (Adiuva Capital)
- Sunday Natural GmbH
- Transform8 GmbH
- Trilantic
Work highlights
- Advising Sunday Natural on the sale of a stake to CVC Capital Partners including re-investment in the acquisition structure.
- Advising Kiteworks on the acquisition of ownCloud GmbH and DRACOON GmbH.
- Advising Sanecum on various transactions in the healthcare sector, including transactions for the acquisition of nephrology and cardiology practices as well as radiology practices, including in the mid-cap sector.